ATE440286T1 - Beurteilung von nervenschäden anhand von blutproben - Google Patents

Beurteilung von nervenschäden anhand von blutproben

Info

Publication number
ATE440286T1
ATE440286T1 AT04758954T AT04758954T ATE440286T1 AT E440286 T1 ATE440286 T1 AT E440286T1 AT 04758954 T AT04758954 T AT 04758954T AT 04758954 T AT04758954 T AT 04758954T AT E440286 T1 ATE440286 T1 AT E440286T1
Authority
AT
Austria
Prior art keywords
assessment
blood samples
nerve damage
detected
breakdown products
Prior art date
Application number
AT04758954T
Other languages
English (en)
Inventor
Gerry Shaw
Brian Pike
Sonal Tuli
Original Assignee
Univ Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida filed Critical Univ Florida
Application granted granted Critical
Publication of ATE440286T1 publication Critical patent/ATE440286T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Neurology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Neurosurgery (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
AT04758954T 2003-03-31 2004-03-26 Beurteilung von nervenschäden anhand von blutproben ATE440286T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45928603P 2003-03-31 2003-03-31
PCT/US2004/009114 WO2004091379A2 (en) 2003-03-31 2004-03-26 Assessing neuronal damage from blood samples

Publications (1)

Publication Number Publication Date
ATE440286T1 true ATE440286T1 (de) 2009-09-15

Family

ID=33299668

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04758954T ATE440286T1 (de) 2003-03-31 2004-03-26 Beurteilung von nervenschäden anhand von blutproben

Country Status (10)

Country Link
US (3) US20040241762A1 (de)
EP (1) EP1613204B1 (de)
JP (1) JP4557971B2 (de)
AT (1) ATE440286T1 (de)
AU (1) AU2004229317B2 (de)
CA (1) CA2520945C (de)
DE (1) DE602004022645D1 (de)
DK (1) DK1613204T3 (de)
ES (1) ES2332136T3 (de)
WO (1) WO2004091379A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2367311T3 (es) * 2004-04-15 2011-11-02 University Of Florida Research Foundation, Inc. Productos de degradación proteolítica de map-2 como biomarcadores de diagnóstico para las lesiones neurales.
US20070276275A1 (en) * 2006-05-24 2007-11-29 University Of Miami Screening method and system to estimate the severity of injury in critically ill patients
EP2124056A4 (de) * 2006-12-27 2010-06-02 Japan Science & Tech Agency Immunologisches nachweisverfahren unter verwendung von vogelantikörper
US20140038834A1 (en) * 2010-07-07 2014-02-06 Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patiëntenzorg Novel biomarkers for detecting neuronal loss
CN106461645A (zh) * 2014-04-07 2017-02-22 铁马诊断公司 外伤性脑损伤和神经退行性生物标记物、方法和系统
WO2020023899A1 (en) * 2018-07-27 2020-01-30 Veravas, Inc. Methods for depletion and enrichment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU86652A1 (de) * 1986-11-10 1988-06-13 Progen Biotechnik Gmbh Verfahren zum auffinden von gewebslaesionen
ES2094733T3 (es) * 1988-12-21 1997-02-01 Gen Hospital Corp Deteccion de enfermedades o disfunciones neurologicas.
US5595722A (en) * 1993-01-28 1997-01-21 Neorx Corporation Method for identifying an agent which increases TGF-beta levels
GB9719879D0 (en) * 1997-09-19 1997-11-19 Neuropa Ltd Protein
US6589746B1 (en) * 1999-10-21 2003-07-08 University Of Cincinnati Method of detecting axonally-derived protein tau in patients with traumatic CNS injury

Also Published As

Publication number Publication date
JP4557971B2 (ja) 2010-10-06
JP2006522336A (ja) 2006-09-28
HK1085538A1 (en) 2006-08-25
DE602004022645D1 (de) 2009-10-01
WO2004091379A3 (en) 2005-12-22
US20100184105A1 (en) 2010-07-22
DK1613204T3 (da) 2009-12-07
WO2004091379A2 (en) 2004-10-28
EP1613204A2 (de) 2006-01-11
CA2520945A1 (en) 2004-10-28
ES2332136T3 (es) 2010-01-27
CA2520945C (en) 2014-03-25
AU2004229317A1 (en) 2004-10-28
EP1613204B1 (de) 2009-08-19
US20160349272A1 (en) 2016-12-01
US20040241762A1 (en) 2004-12-02
EP1613204A4 (de) 2007-04-04
AU2004229317B2 (en) 2012-01-12

Similar Documents

Publication Publication Date Title
TW200643400A (en) Optical-based sensing devices
ATE520974T1 (de) Raman-spektralanalyse von unter der oberfläche liegenden geweben und flüssigkeiten
ATE330038T1 (de) Nukleinsäure-biosensor
ATE482744T1 (de) Vorrichtung zur erkennung und behandlung von depressionen
CR8372A (es) Sistema de deteccion rapida de oclusion en bomba de jeringa
BRPI0606807A2 (pt) dispositivo para analisar partìculas em uma amostra e método para analisar partìculas em uma amostra que contém as referidas partìculas
WO2008108792A3 (en) An integrated airborne substance collection and detection system
EP1415152A4 (de) Verfahren, vorrichtungen und computerprogramme zum verifizieren der integrität einer sonde
EP3991676A4 (de) Ablationssystem und nervendetektionsvorrichtung dafür
EP1604203A4 (de) Verfahren zum direkten nachweis einzelner methotrexatmetabolite
PH12019502710A1 (en) Fgfr2 inhibitors for the treatment of cholangiocarcinoma
WO2019139980A8 (en) Methods for measuring analyte and/or protein in biological samples
WO2005080985A3 (en) Methods and compositions for detecting and treating autoimmune diseases
WO2004057341A3 (en) Cvd assay
WO2009099905A3 (en) Molecular signatures and biomarkers associated with melanoma and methods of use thereof
WO2014100150A8 (en) Device and methods for detection of analytes including use of a colorimetric barcode
EP2211176A3 (de) Analyse von Nervenzellenbeschädigungen
WO2009007649A3 (fr) Dispositif et procede d'identification et de determination de groupes sanguins
DE602005000485D1 (de) Nukleinsäurenachweisverfahren mittels mehreren Paaren von Donorflurophoren und Quenchemolekülen in derselben Sonde
DE602006016726D1 (de) Biologische Detektionsvorrichtung, Vorrichtung zur Authentifizierung von Fingerabdrücken und biologisches Detektionsverfahren
DE602004022645D1 (de) Beurteilung von nervenschäden anhand von blutproben
ATE452990T1 (de) Verfahren zur zählung und identifikation von mikroorganismen
EP3937359A4 (de) Fördervorrichtung und probenanalysesystem und probenvorverarbeitungsvorrichtung damit
DE602006012684D1 (de) Katheter zur Abnahme von Blut
WO2005090596A3 (en) Assay for detecting and identifying micro-organisms

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties